Ignite Creation Date:
2025-12-25 @ 4:48 AM
Ignite Modification Date:
2025-12-26 @ 3:50 AM
Study NCT ID:
NCT00851318
Status:
COMPLETED
Last Update Posted:
2014-11-03
First Post:
2009-02-23
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-03
Start Date Type:
None
Primary Completion Date:
2013-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-06
Completion Date Type:
ACTUAL
First Submit Date:
2009-02-23
First Submit QC Date:
None
Study First Post Date:
2009-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-09-09
Results First Submit QC Date:
None
Results First Post Date:
2014-09-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-27
Last Update Post Date:
2014-11-03
Last Update Post Date Type:
ESTIMATED